PanTher Therapeutics
PanTher Therapeutics, Inc.
PanTher Therapeutics, Inc. is a clinical-stage oncology company that focuses on revolutionizing cancer treatment through localized therapy. By addressing the inefficiencies of systemic drug delivery, PanTher aims to enhance cancer therapies and minimize side effects for patients.
Products & Team
PTM-101
PTM-101 is an innovative, absorbable polymer film designed to deliver paclitaxel, a potent chemotherapy agent, directly to the peritumoral region. This targeted delivery method allows for sustained, high-dose administration while avoiding the systemic side effects typically associated with chemotherapy.
PTM-101 addresses the limitations of systemic chemotherapy by ensuring that a significantly higher concentration of therapeutic agents reaches the tumor site, leading to improved efficacy and reduced toxicity.
The inefficiency of systemic chemotherapy, the limited drug reach to tumor sites, and the associated systemic side effects that affect patient quality of life.